Vutrisiran: a new drug in the treatment landscape of hereditary transthyretin amyloid polyneuropathy

.

Source: Expert Opinion on Drug Discovery - January 28, 2024 Category: Drugs & Pharmacology Authors: Violaine Plant é-BordeneuveValentine Perraina Department of Neurology, Henri Mondor University Hospital, AP-HP, Créteil, Franceb Mondor Biomedical Research Institute – IMRB, INSERM, U955 Team 10 “Biology of the Neuromuscular System”, Créteil, Fra Source Type: research